Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NH002 for Cardiac Echocardiography
NCT07740421Phase 3Not yet recruiting
- Sponsor
- Trust Bio-sonics Inc.
- Start
- Jul 2026
- Primary completion
- Jul 2027
01
Overview
A Phase 3 trial of perflutren lipid microspheres in heart disease, sponsored by Trust Bio-sonics Inc.. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
perflutren lipid microspheres
03
Conditions
heart disease
Beyond the preview
Go deeper on NCT07740421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07740421.